UPDATED May 21, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CARA | kr18.45 | -1.6% | 20.6% | kr1.3b | kr26.50 | PS5.3x | E113.0% | 10.0% | Healthcare | ||
A335890 | ₩11,140.00 | 7.6% | 75.4% | ₩643.3b | ₩12,500.00 | PE45x | E29.3% | 0.2% | Healthcare | ||
2324 | CN¥10.01 | -7.4% | -30.0% | CN¥11.0b | CN¥11.80 | PE24.9x | E32.3% | 0.5% | Materials | ||
MBB | ₫23,600.00 | 3.3% | 44.7% | ₫124.8t | ₫32,033.75 | PB1.3x | E17.5% | 1.8% | Banks | ||
2334 | CN¥6.81 | 0% | -49.3% | CN¥5.5b | CN¥13.00 | PE17x | E24.8% | 0.9% | Capital Goods | ||
ENFN | US$9.22 | -0.4% | 20.5% | US$1.2b | US$9.82 | PE421.8x | E99.0% | n/a | Software | ||
LAB B | Mex$16.62 | -2.8% | 12.4% | Mex$16.2b | Mex$19.46 | PE15.1x | E28.6% | 4.7% | Pharmaceuticals & Biotech | ||
HTCR | US$0.70 | -17.7% | -65.0% | US$14.6m | US$3.00 | PB2.8x | E145.6% | 11.4% | Software | ||
GVR | €1.37 | 4.9% | 30.5% | €794.3m | €1.61 | PE16.9x | E22.5% | n/a | Consumer Durables | ||
A214420 | ₩10,170.00 | 8.1% | 102.2% | ₩233.8b | n/a | PE65.7x | E44.0% | 0% | Household | ||
ORRF | US$26.80 | 0.1% | 43.3% | US$287.3m | US$31.33 | PB1.1x | E55.9% | 3.0% | Banks | ||
IBU | €13.30 | -1.5% | -45.2% | €63.2m | €14.50 | PS1.3x | E98.0% | 0.3% | Materials | ||
ELB | €2.44 | -2.4% | 4.3% | €13.9m | €8.00 | PB1.7x | E99.1% | n/a | Consumer Durables | ||
VCTR | US$52.80 | 2.6% | 72.4% | US$3.4b | US$51.50 | PE15.6x | E30.6% | 2.8% | Diversified Financials | ||
2748 | NT$71.90 | -2.2% | -22.4% | NT$7.6b | NT$87.67 | PE22.2x | E22.7% | 2.8% | Consumer Services | ||
300767 | CN¥11.16 | 2.7% | -63.3% | CN¥2.8b | CN¥35.20 | PS4.1x | E70.1% | 0% | Materials | ||
6967 | JP¥5,600.00 | 1.0% | 20.4% | JP¥757.6b | JP¥6,242.22 | PE40.7x | E28.4% | 0% | Semiconductors | ||
CAPMAN | €1.93 | 0% | -25.8% | €341.3m | €2.30 | PE96.6x | E35.1% | 5.2% | Diversified Financials | ||
ZAL | €23.96 | -2.8% | -20.4% | €6.2b | €32.98 | PE55x | E27.0% | n/a | Retail | ||
CIRC | €7.26 | 8.7% | 56.5% | €29.0m | €8.00 | PE20.7x | E22.5% | n/a | Commercial Services | ||
600388 | CN¥12.28 | -5.4% | -26.9% | CN¥13.2b | CN¥17.43 | PE25.3x | E34.4% | 1.6% | Capital Goods | ||
CDXC | US$3.16 | -13.7% | 110.0% | US$238.6m | US$6.34 | PS2.9x | E99.5% | n/a | Pharmaceuticals & Biotech | ||
2469 | JP¥2,324.00 | 8.3% | 58.9% | JP¥21.6b | JP¥3,600.00 | PE14.2x | E22.8% | 1.3% | Tech | ||
CLSK | US$18.42 | 7.6% | 312.1% | US$4.2b | US$23.33 | PE63.9x | E17.0% | n/a | Software |